Medical use of interferon-lambda for the treatment of fibrosis
US11975046B2 · kind B2 · utility
0Cited by
0References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 29, 2023 |
| Grant date | May 7, 2024 |
| Priority date | — |
| Expiry date | Jun 29, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods for the treatment of fibrosis. The invention discloses new research which demonstrates that interferon-lambda has directly acting anti-fibrotic effects both in vitro and in vivo and may be used to provide effective new therapies for the treatment of multiple types of fibrosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.